When Slc2a1 was excised after the cells had grown as tumors in vivo (i.e., when cells were cultured from control tumors and then treated with Cre recombinase), a decrease in tumor growth rates and glucose uptake was observed in the absence of GLUT1, but tumors formed. Here, SLC2A1 is linked to neoplasm.